Immunotherapy Treatment Articles & Analysis
18 articles found
Enter immunotherapy - a groundbreaking approach that is not only redefining leukemia treatment but also offering new hope as a potent solution provider for this challenging condition. Immunotherapy in Leukemia Treatment Immunotherapy represents a paradigm shift in the treatment of leukemia. ...
By attaching drugs or other therapeutic agents to antibodies that have high selectivity for cancer cells, we can deliver potent treatment directly to the disease site, thereby minimizing systemic side effects. ...
Creative Biogene is one of the leading biotechnology companies which has the expertise and ability in providing CpG oligodeoxynucleotides synthesis service for customers worldwide. Creative Biogene's sophisticated equipments, advanced technologies and highly experienced staffs are available to assist you synthesis your interested CpG oligodeoxynucleotides. Creative Biogene's goal is to provide ...
Researchers state that enoblituzumab, as a new treatment approach, primarily works by relieving the inhibition of the immune system's recognition and elimination of cancer cells by B7-H3. ...
Summary In this Cell Patterns publication, Ozette co-founders and collaborators at the Cancer Immunotherapy Trials Network (CITN) outline a novel method of analysis of single cell data, FAUST, and validate the multiple potential applications. ...
Currently, ADC has played a significant role in the treatment of some malignant tumors, such as trastuzumab in the treatment of breast cancer, but its application in the treatment of prostate cancer (PCa) progress slowly. In recent years, ADC has made rapid progress in the treatment of metastatic castration-resistant prostate ...
The advent of immunotherapies for cancer, and more recently of cellular immunotherapies, has substantially altered the treatment landscape. ...
Our research, along with our partners at Duke Health, found there were significant health care delays for people of color when they tried to obtain immunotherapy treatment. Delays related to timeliness in obtaining treatment can be complex and multifactorial and cause differential access to treatment. ...
Evaluating mass implementation of digital health solutions to improve quality and reduce disparities in a large multisite community oncology practice (Oral Presentation) Analyzing patient engagement with digital health tools to facilitate equity across a large statewide community oncology practice (Poster Presentation) Racial disparity in receipt of immunotherapy ...
No approved preventive vaccines, immunotherapies, or reliable treatments are currently available to cure herpes, says the WHO and the U.S. ...
Immunotherapy, in addition to surgery, chemotherapy, and radiotherapy, has now become the fourth pillar of anticancer treatment, with T cell-based immunotherapy being a successful cancer treatment technique. ...
They can help clinicians and patients choose the best treatment, and can allow patients to avoid unnecessary or impossible treatments. Dr. Panageas said, "Immunotherapy drugs are not without potential side effects. Therefore, if we can save someone from the potential risks of a certain treatment, because we know they cannot ...
Therapeutic vaccines may well be the next wave of immunotherapy for cancer treatment. Peptide-based vaccines will play a pivotal role in the field. ...
About Treos Bio Limited Treos Bio uses computational data science and proprietary biomarkers to develop precision off-the-shelf and personalized peptide-based cancer immunotherapies. The Company has developed a unique ability to match the antigens expressed by a specific cancer to the individual patient’s target recognition mechanism (HLA). This technology aims to address ...
How autoantibody profiling can further unlock the success of CPI therapy Immunotherapy has revolutionised the treatment of cancers, improving the prognosis for a variety of malignancies. One of the key elements in the immunotherapy war chest are checkpoint inhibitors (CPIs) which have been the main drivers behind this progress. ...
The research summarized in this whitepaper provides a number of examples of how ALZET® pumps offer a superior pre-clinical drug dosing option for the delivery of a wide array of anti-cancer agents, including small molecules, immunotherapies, radiotherapies, combination treatments, and novel drug entities. This whitepaper also explores how ALZET® pumps ...
Future Treatment: Immunotherapies Immunotherapies have been adopted as an approach to treating autoimmune conditions such as type 1 diabetes. ...
Cancer therapy should aim to prevent recurrent disease. Surgery and toxic treatments remove only symptoms associated with cancer without trying to intervene in the aetiology, therefore the disease may recur. ...
